Intuitive Surgical fundamentals remain strong, says William Blair William Blair believes Intuitive Surgical's fundamentals remain strong following the company's buyback announcement and its call with Dr. Mario Leitao, gynecologic oncologist and co-director of the robotic surgery program at the Memorial Sloan-Kettering Cancer Center. The firm notes that Dr. Leitao does not believe recent reports on safety will change utilization on Intuitive Surgical's da Vinci. William Blair keeps an Outperform rating on the stock.
Intuitive Surgical upgraded to Outperform from Market Perform at Leerink Leerink upgraded Intuitive Surgical to Outperform saying it has greater confidence in the company's ability to accelerate procedure growth after surveying surgeons. The firm raised its price target for shares to $560 from $450.